Phosphate Salt of Tricyclic Nucleoside

Suppliers

Names

[ CAS No. ]:
61966-08-3

[ Name ]:
Phosphate Salt of Tricyclic Nucleoside

[Synonym ]:
5-Methyl-1-(5-O-phosphono-b-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,8-pentaazaacenaphthylen-3-amine
5-Methyl-1-(5-O-phosphono-β-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,8-pentaazaacenaphthylen-3-amine
Pentaazaacenaphthylene-5' phosphate ester
3-Amino-1,5-dihydro-5-methyl-1-b-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylene 5'-(Dihydrogen Phosphate)
Phosphate Salt of Tricyclic Nucleoside
Triciribine phosphate (USAN)
1,4,5,6,8-Pentaazaacenaphthylen-3-amine, 1,5-dihydro-5-methyl-1-(5-O-phosphono-β-D-ribofuranosyl)-
VQD-002
TCN-P

Chemical & Physical Properties

[ Density]:
2.2±0.1 g/cm3

[ Boiling Point ]:
832.8±75.0 °C at 760 mmHg

[ Molecular Formula ]:
C13H17N6O7P

[ Molecular Weight ]:
400.28

[ Flash Point ]:
457.4±37.1 °C

[ Exact Mass ]:
400.089630

[ PSA ]:
200.81000

[ LogP ]:
-2.83

[ Vapour Pressure ]:
0.0±3.2 mmHg at 25°C

[ Index of Refraction ]:
1.925

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
RY8450000
CHEMICAL NAME :
1,4,5,6,8-Pentaazaacenaphthylen-3-amine, 1,5-dihydro-5-methyl-1-(5-O-phosphono-beta-D- ribofuranosyl)-
CAS REGISTRY NUMBER :
61966-08-3
LAST UPDATED :
198605
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C13-H17-N6-O7-P
MOLECULAR WEIGHT :
400.33

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
193 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
109 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986

Related Compounds

  • SODIUM AMMONIUM HYDROGEN PHOSPHATE TETRAHYDRATE
  • Melamine salt of cage phosphate
  • tricyclohexylammonium salt of L-ascorbic acid 2-O-phosphate
  • tetrabutylammonim salt of diethylphosphoric acid
  • pyridinium salt of 2,3,4,6-tetra-O-acetyl α-D-glucopyranosyl phosphate
  • sodium salt of 2-bromophenol
  • 2-(4-chlorophenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-3,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amine
  • 2-(4-Chlorophenyl)-3,5-dimethyl-7-(4-methylpiperidin-1-yl)pyrazolo[1,5-a]pyrimidine
  • 2-(4-chlorophenyl)-N-(4-fluorophenyl)-3,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amine
  • 2-(2-{[2-(4-Chlorophenyl)-3,5-dimethylpyrazolo[1,5-a]pyrimidin-7-yl]amino}ethoxy)ethanol
  • 2-(4-chlorophenyl)-3,5-dimethyl-N-(2-methylpropyl)pyrazolo[1,5-a]pyrimidin-7-amine
  • N-[4-(3-bromophenyl)-1,3-thiazol-2-yl]-2-(pyrimidin-2-ylsulfanyl)acetamide
  • 7-Phenylpyrazolo[1,5-a][1,3,5]triazine-2,4-diamine
  • N-(4-hydroxypyridin-3-yl)piperidine-4-carboxamide
  • N-(6-methoxy-1,3-benzothiazol-2-yl)-3-methyl-5-phenyl-1,2-oxazole-4-carboxamide
  • [(2,5-Dimethylphenyl)methyl](2-methylpropyl)amine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.